News Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance Continue Reading Previous New Data From an Influenza Challenge Study Further Support the Prophylactic Potential of INNA-051 to Accelerate Viral ClearanceNext Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance Related Stories News We Write Code Adopts WWC as Public-Facing Name, Reorganizes Around Six Services and Puts AI at the Center News Senteon and MSP Glass Announce Integration to Unify Endpoint Hardening Visibility for Managed Service Providers News NexusTek Brings Forward Deployed Engineering to the Mid-Market News Snail Games USA Launches Dead Party, Expanding Its Cooperative Multiplayer Portfolio News Enable and Guidewheel Explore AI-Powered Pricing Linked to Real-Time Manufacturing Capacity News Shufti Launches Know Your Agent to Verify AI Agent Identity, Human Authorization & Permissions in a Single Flow
